Chronic viral hepatitis in childhood

被引:15
|
作者
Bortolotti, F
机构
来源
BAILLIERES CLINICAL GASTROENTEROLOGY | 1996年 / 10卷 / 02期
关键词
D O I
10.1016/S0950-3528(96)90002-0
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
In endemic areas infection with hepatitis B virus is a common cause of chronic liver disease in childhood. High levels of viral replication and mild ALT abnormalities are the rule in children infected perinatally and many of them are likely to maintain viral replication through their youth. Conversely about 90% of children infected later in life clear HBeAg and achieve sustained remission of liver disease before reaching adulthood. The eventual outcome of infection and disease in these patients remains unpredictable as reactivation of liver damage and viral replication may occur after several years of sustained remission. Cirrhosis is a rare and early complication of chronic HBV infection in children, and a risk faster for hepatocellular carcinoma. IFN therapy can accelerate HBV DNA clearance, improving the spontaneous anti-HBe seroconversion rate in Caucasian children by two to three times. Hepatitis delta is the most severe form of chronic viral hepatitis in childhood. Cirrhosis can be diagnosed in up to 26% of patients at presentation, and few cases respond to IFN therapy. Hepatitis C is relatively rare in children. Before the discovery of HCV, blood transfusions were the most common source of infection. Hepatitis C is usually a mild, asymptomatic disease in otherwise healthy children, but has a poor propensity to spontaneous remission over the years. For this reason, and based on the experience in adults, IFN treatment is now being evaluated.
引用
收藏
页码:185 / 206
页数:22
相关论文
共 50 条
  • [21] Management of chronic viral hepatitis
    Vail, BA
    AMERICAN FAMILY PHYSICIAN, 1997, 55 (08) : 2749 - 2756
  • [22] Nosocomial Chronic Viral Hepatitis
    Sirmatel, F.
    Peksel, H.
    Gursoy, B.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2008, 12 : E416 - E416
  • [23] The treatment of chronic viral hepatitis
    Hoofnagle, JH
    DiBisceglie, AM
    NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (05): : 347 - 356
  • [24] Treatment of chronic viral hepatitis
    Böker, KH
    Manns, MP
    INTERNIST, 1999, 40 (12): : 1275 - 1287
  • [25] Treatment of chronic viral hepatitis
    Main, J
    McCarron, B
    Thomas, HC
    ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, 1998, 9 (06): : 449 - 460
  • [26] CHRONIC VIRAL-HEPATITIS
    DEGOTT, C
    CHEVALLIER, M
    ANNALES DE PATHOLOGIE, 1993, 13 (04) : 219 - 232
  • [27] Treatment of chronic viral hepatitis
    Ferenci, P
    BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2004, 18 : 113 - 120
  • [28] Treatment of chronic viral hepatitis
    Berg, T
    Hopf, U
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1997, 122 (51-52) : 1593 - 1598
  • [29] Interleukines in chronic viral hepatitis
    Loginov, AS
    Tsaregorodtseva, TA
    Zotina, MA
    Serova, TI
    Yakimchuk, GN
    Fedotova, TF
    TERAPEVTICHESKII ARKHIV, 2001, 73 (02) : 17 - 20
  • [30] CHRONIC VIRAL-HEPATITIS
    GARCIA, G
    GENTRY, KR
    MEDICAL CLINICS OF NORTH AMERICA, 1989, 73 (04) : 971 - 983